NEW YORK, May 14, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a life sciences company creating a diversified portfolio of medical technology assets, has today announced the appointment of Dr. Steven Victor ("Dr. Victor") as the third member of the Company's medical advisory board. As the Company continues to evaluate potentially lucrative opportunities in the life sciences space, including the recently announced Memorandum of Understanding ("MOU") with Constellation Diagnostics, Inc. ("Constellation"), Dr. Victor, President of ReGen Medical, has a vast knowledge base as a world renowned dermatologist and is of great importance to the Company. In addition, Dr. Victor's entrepreneurial business mind enhances the Company's access to potentially lucrative opportunities in the life sciences space. As the third member of the Company's medical advisory board, Dr. Victor will join Dr. Lawrence A. May ("Dr. May"), an internist with 35 years of clinical experience, and the Company's Chief Operating Officer, Dr. Stella M. Sung ("Dr. Sung"), an experienced biotech venture capitalist. The Company is working diligently to attract additional members to its Medical Advisory Board with the ultimate goal of securing five to seven outstanding members with the optimal balance of scientific and clinical expertise and relevant sector experience in medical devices, biopharmaceuticals, diagnostics and consumer health care.